An update on pharmacotherapy of autism spectrum disorder in children and adolescents-Reference-Cited by-同舟云学术

An update on pharmacotherapy of autism spectrum disorder in children and adolescents

Published:2018-01-02 Issue:1 Volume:30 Page:78-95
ISSN:0954-0261
Container-title:International Review of Psychiatry
language:en
Short-container-title:International Review of Psychiatry

Author:

Goel Ritu¹²,Hong Ji Su¹²,Findling Robert L.¹²,Ji Na Young¹²

Affiliation:

1. Department of Psychiatry, Kennedy Krieger Institute, Baltimore, MD, USA;

2. Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.1080/09540261.2018.1458706

Reference110 articles.

1. Effect of a vitamin/mineral supplement on children and adults with autism

2. Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension

3. Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial

4. Diagnostic and Statistical Manual of Mental Disorders

5. Anagnostou, E., Brian, J. A., Campo-Soria, C., Capano, L., Esler, A. N., Hudock, R. … Jacob, S. (2017). A randomized controlled trial of intranasal oxytocin in autism spectrum disorder. Oral presentation at the International Meeting for Autism Research (IMFAR), San Francisco.

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential brain biomarkers in patients with Autism spectrum syndrome;Research in Autism Spectrum Disorders;2024-10

2. Behavioral Interventions with and without Pharmacological Treatment: A Comparative Study at An Autistic Center in Jordan;Jordan Journal of Pharmaceutical Sciences;2024-06-25

3. The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder;Neuropharmacology;2024-05

4. Probing heterogeneity to identify individualized treatment approaches in autism: Specific clusters of executive function challenges link to distinct co-occurring mental health problems;Autism;2024-04-20

5. Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder;Autism Research;2024-03-18